Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 16.85
+0.20 (1.20%)
At close: Aug 27, 2026
Vytrus Biotech Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 9.69 | 9.69 | 6.09 | 4.7 | 4.48 | 3.51 |
Revenue Growth | 19.88% | 59.15% | 29.51% | 4.90% | 27.57% | 57.47% |
Gross Profit Gross Profit Growth | 8.83 | 8.83 | 5.5 | 4.35 | 4.13 | 3.25 |
Operating Income Operating Income Growth | 3.16 | 3.16 | 0.98 | 0.4 | 0.61 | 0.41 |
Net Income Net Income Growth | 2.9 | 2.9 | 1.02 | 0.54 | 0.61 | 0.45 |
Earnings Per Share EPS Growth | 0.39 | 0.39 | 0.14 | 0.08 | - | 0.06 |
EPS Growth | - | 183.99% | 67.72% | - | - | 106.59% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Spain Spain Growth | 2.59 | 2.59 | 1.51 | 1.47 | 1.26 | 1.03 |
European Union European Union Growth | 2.62 | 2.62 | 1.67 | 1.09 | 1.38 | 1.2 |
Other Export Other Export Growth | 3.17 | 3.17 | 1.87 | 1.18 | 1.05 | 0.57 |
Total Total Growth | 8.37 | 8.37 | 5.04 | 3.74 | 3.68 | 2.8 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.44 | 3.44 | 2.53 | 1.11 | 0.72 | 1.28 |
Total Debt Total Debt Growth | 1.24 | 1.24 | 1.77 | 2.08 | 0.98 | 0.93 |
Net Cash (Debt) Net Cash Growth | 2.2 | 2.2 | 0.76 | -0.97 | -0.26 | 0.35 |
Net Cash Growth | 17.81% | 190.78% | - | - | - | 57.68% |
Net Cash Per Share Net Cash Per Share Growth | 0.29 | 0.29 | 0.10 | -0.14 | - | 0.05 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3.9 | 3.9 | 1.84 | 0.9 | 1.03 | 0.45 |
Capital Expenditures CapEx Growth | -1.01 | -1.01 | -0.1 | -0.14 | -0.42 | -0.22 |
Free Cash Flow Free Cash Flow Growth | 2.89 | 2.89 | 1.74 | 0.76 | 0.61 | 0.23 |
Free Cash Flow Growth | 6.88% | 65.63% | 128.46% | 25.94% | 166.43% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 91.10% | 91.10% | 90.28% | 92.46% | 92.14% | 92.60% |
Operating Margin | 32.56% | 32.56% | 16.17% | 8.60% | 13.53% | 11.65% |
Pretax Margin | 32.25% | 32.25% | 14.81% | 6.56% | 10.10% | 8.80% |
Profit Margin | 29.89% | 29.89% | 16.76% | 11.59% | 13.50% | 12.81% |
FCF Margin | 29.78% | 29.78% | 28.62% | 16.22% | 13.51% | 6.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 43.72 | 22.21 | 15.95 | 23.17 | 38.81 | - |
Forward PE | - | 20.43 | 21.98 | 11.97 | 26.21 | - |
P/FCF Ratio | 43.88 | 22.29 | 9.35 | 16.55 | 38.78 | - |
PS Ratio | 13.07 | 6.64 | 2.67 | 2.69 | 5.24 | - |